Business management guru and author Michael Porter laid out his generic marketing strategies in his 1985 book "Competitive Advantage: Creating and Sustaining Superior Performance." Porter identified ...
The Competitive Generic Therapy designation looks to encourage the development of alternatives for drugs with inadequate generic competition. The Food and Drug Administration on Wednesday approved a ...
The FDA Reauthorization Act of 2017 (FDARA) created a new pathway to incentivize the development of generic drugs where there is inadequate competition. Under this new pathway [new Section 506H of the ...
A focused differentiation strategy combines elements of two of the three generic business strategies identified in the strategic framework of Michael Porter, management expert and author of ...
Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
NEW YORK (Jan. 14, 2013) -- Replacing the combination of brand-name, antiretroviral drugs currently recommended for control of HIV infection with soon-to-be-available generic medications could save ...
President Joe Biden campaigned on the goal of lowering prescription drug costs. So far, those promises haven't amounted to much. But late last week, the president unveiled a series of initiatives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results